Back
Ares Capital Vs. Insmed Industry Stock Comparison
Sell
47
ARCC
Ares Capital
Last Price:
21.04
Seasonality Move:
0.96%
Buy
65
INSM
Insmed
Last Price:
72.22
Seasonality Move:
4.27%
Sell
47
Ares Capital (ARCC)
is a Sell
Is Ares Capital a Buy, Sell or Hold?
- The current Ares Capital [ARCC] share price is $21.05. The Score for ARCC is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- ARCC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
65
Insmed (INSM)
is a Buy
Is Insmed a Buy, Sell or Hold?
- The current Insmed [INSM] share price is $72.28. The Score for INSM is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
- INSM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ARCC Stock Price Chart
What is Ares Capital's stock price today?
-
The Ares Capital share price today is $21.05
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ARCC is experiencing buying pressure, which is a positive indicator for future bullish movement.
INSM Stock Price Chart
ARCC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.05 | Buy |
Relative Strength Index (14 RSI): | 58.9 | Buy |
Chaikin Money Flow: | 2063715 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (20.45 - 20.93) | Buy |
Bollinger Bands (100): | (20.55 - 21.25) | Buy |
INSM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.45 | Sell |
Relative Strength Index (14 RSI): | 46.34 | Sell |
Chaikin Money Flow: | 515638 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (71.86 - 74.32) | Sell |
Bollinger Bands (100): | (51.81 - 81.07) | Buy |
ARCC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 20.82 | Buy |
20-day SMA: | 20.64 | Buy |
50-day SMA: | 20.71 | Buy |
200-day SMA: | 20.62 | Buy |
8-day EMA: | 20.84 | Buy |
20-day EMA: | 20.75 | Buy |
50-day EMA: | 20.75 | Buy |
200-day EMA: | 20.52 | Buy |
INSM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 72.58 | Sell |
20-day SMA: | 72.92 | Sell |
50-day SMA: | 73.99 | Sell |
200-day SMA: | 47.03 | Buy |
8-day EMA: | 72.53 | Sell |
20-day EMA: | 73.04 | Sell |
50-day EMA: | 71.92 | Buy |
200-day EMA: | 53.13 | Buy |
Ares Capital Earnings Growth & ARCC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.04 per share, and a decrease next year of $0.17 per share.
Insmed Earnings Growth & INSM Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.10 per share, and an increase next year of $1.08 per share.
Ares Capital Technical Analysis
Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | Oct | |||||||||
23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Insmed Technical Analysis
Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | Oct | |||||||||
23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |